Enrol today

Long COVID: Dysautonomia
& POTS 

Access

12 months

Format

Online Masterclass

Duration

4.5 hours

Presenters


Prof. David Putrino, Dr. Elizabeth Steels, Dr. Jason Kaplan & Hugh Dunstan

In exploring post-COVID conditions such as POTS and dysautonomia, doctors will not only gain insights into the intricacies of these conditions but also learn effective strategies for managing them. Delving deeper into the nuances of POTS and dysautonomia, healthcare professionals can develop a comprehensive understanding of the multifaceted nature of these disorders and refine their approaches to diagnosis, treatment, and long-term care. By incorporating a nutraceutical approach alongside traditional drug-based treatments, doctors can expand their therapeutic toolkit and offer more tailored and holistic care to patients experiencing post-COVID autonomic dysfunction.

In this masterclass, Professor David Putrino explores Dysautonomia and POTS, alongside a workshop led by Dr. Elizabeth Steels, Dr. Jason Kaplan & Hugh Dunstan. The course also includes the Dysautonomia & POTS Protocol, providing an excellent resource for clinical application.

Course Overview

Topic
PRESENTER
Dysautonomia and POTS
Prof. David Putrino
Workshop: POTS
Prof. David Putrino, Dr. Elizabeth Steels, Dr. Jason Kaplan & Hugh Dunstan
Dysautonomia & POTS Protocol

MEET THE PRESENTERS

Professor David Putrino

PT, PhD
David is a physical therapist with a PhD in Neuroscience. He is currently the Director of Rehabilitation Innovation for the Mount Sinai Health System, and a Professor of Rehabilitation and Human Performance at the Icahn School of Medicine at Mount Sinai. He develops innovative rehabilitation solutions for adults and children in need of better healthcare accessibility, and in 2019, he was named “Global Australian of the Year” for his contributions to healthcare. Since the beginning of the COVID-19 pandemic in 2020, David has been recognized globally as a leading expert in the assessment, treatment and underlying physiology of long COVID. His team has managed the care of almost 2000 people with long COVID and published multiple peer-reviewed scientific papers on the topic.

Dr. Elizabeth Steels

PhD, BA(Clin Biochem), BA(Nutr Diet) 
Dr. Elizabeth Steels is a biomedical scientist, biochemist, and nutritionist. Having completed her PhD 30 years ago focussed on cellular oxygenation and regeneration, her interests became firmly fixed on the value of polyphenols in health and disease. Her career has ranged from pharmaceutical to natural medicine manufacturing, product development, formulations, clinical trials, clinical practice and regulatory affairs. She is an Adjunct Senior Research Fellow in the Dept of Pharmacy, School of Medicine, University of Queensland and mentors a growing team of MPhil and PhD students. She is a principal for a CRO specialising in innovative and unique clinical design with a regulatory and commercial focus of natural medicine focussing on innovative claims and clinical trials of polyphenols, eco-cannabinoids and botanicals. She is also Head of Research & Development at Integria Healthcare. She is well-published and often speaks at academic and industry events.

Dr. Jason Kaplan

BSc(Med), MBBS(Hons), FRACP, FCSANZ, FACC
Dr. Jason Kaplan is a cardiac imaging specialist and preventative cardiologist who studied Medicine at UNSW and graduated with Honours in 1999, completing his Internal Medicine Training at St George and Prince of Wales hospitals and Adult Cardiology training at Royal Prince Alfred Hospital. Dr. Kaplan has done additional training in all aspects of echocardiography at international centres including the Mayo Clinic and has been involved in training echo sonographers for the last 10 years. Prior to training in cardiology, Dr. Kaplan completed additional advanced training in medical oncology and pharmacology. His training in these areas allows him to adopt a more holistic approach to patient care, particularly those with multiple medical issues This training has also led to a special interest in the emerging field of cardio-oncology, which is the cardiac care of patients who are undergoing or have previously completed cancer treatment. He is an accredited specialist in Cardiac CT and teaches on a regular basis to other specialists in this discipline. Dr. Kaplan is also a proponent of Integrative Cardiology incorporating principles of cardiovascular, nutritional, functional and Mind – Body Medicine in the care of his patients. In 2019 Dr. Kaplan became a Fellow of the American College of Cardiology being recognised for his contribution to cardiovascular medicine. Dr. Kaplan is currently a senior clinical lecturer in Medicine in the Faculty of Medicine and Health Sciences at Macquarie University teaching undergraduate and postgraduate students.  

Hugh Dunstan

PhD, CEO
Hugh Dunstan has been a university researcher for 40 years and he recently retired in 2020 as a Professor from the University of Newcastle, Australia. He is a highly accomplished research scientist with a vast knowledge of biochemistry, where his research focus was the nature of exercise-induced fatigue and the metabolic processes that underpin it. Hugh worked closely for many years with Professor Tim Roberts and Dr Margaret MacDonald and in 2014, they made a significant breakthrough in understanding the significance of the losses of amino acids in sweat and urine, relative to their corresponding blood levels. This breakthrough provided new insights into the supply and demand for key nutrients in humans and has opened up a completely new understanding of protein turnover and amino acid metabolism. Over the next six years, Hugh and his team continued to investigate amino acid losses in sweat and urine from humans and have published their findings in international peer-reviewed journals. Their research has identified six amino acids that are lost in large quantities in sweat and urine. These same six amino acids have numerous metabolic roles in the body in major areas of body functions: Energy Systems, Growth and Recovery, Structural Integrity and Metabolism. Because of these features, this group of amino acids has been referred to as high-demand amino acids (HDAA). This scientific revelation has led to the formation of InnovAAte Pty Ltd and the development by of novel HDAA supplementation products: ElectrAAte® and OptimatAAte®. The goals of these products are simply to replenish the HDAA and electrolytes for maintaining optimal hydration and an enhanced healthy lifestyle.
A key mission of InnovAAte is to promote the research findings to health professionals and the general public. This insight will give them some tools to better balance key nutrient demands generated by active and healthy lifestyles. Hugh’s research has had a significant impact on the scientific community and has provided a new perspective on the importance of HDAA in maintaining proper hydration and assisting muscle recovery.